During the past decade, MS Center of California conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MS Center of California" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Sanofi" with 2 trials sponsored, "Allergan" with 1 trials sponsored, "Genentech, Inc." with 1 trials sponsored and "MedDay Pharmaceuticals SA" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "MS Center of California" are "Multiple Sclerosis" (3 trials), "Relapsing Multiple Sclerosis" (2 trials), "Multiple Sclerosis, Primary Progressive" (1 trials), "Muscle Spasticity" (1 trials) and "Primary Progressive Multiple Sclerosis" (1 trials). Many other conditions were trialed in "MS Center of California" in a lesser frequency.

Most popular intervention types in "MS Center of California" are "Drug" (9 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (5 trials), "Placebo" (2 trials), "Tolebrutinib" (2 trials), "Interferon beta-1a" (1 trials) and "Interferon beta-1a-matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "MS Center of California" are 9 trials for "All" genders.

Currently, there are NaN active trials in "MS Center of California". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in MS Center of California, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in MS Center of California, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".